Prevalence and associated metabolic factors of nonalcoholic fatty liver disease in the general population from 2014 to 2018 in Japan: A large‐scale multicenter retrospective study

Abstract

AimThe prevalence of nonalcoholic fatty liver disease (NAFLD) is increasing worldwide. The aim of this study was to determine the recent prevalence and clinical characteristics of NAFLD in Japan.MethodsThis study initially included 410,061 retrospectively enrolled adults from the medical health checkup registry for metabolic syndrome, chronic kidney disease, and fatty liver in Japan (MIRACLE‐J; UMIN‐CTR no. UMIN000049419), who were evaluated between 2014 and 2018 at 13 health centers in Japan. Subjects consuming > 20 g of alcohol/day or with chronic liver disease were excluded. Fatty liver was diagnosed by ultrasonography. The probability of NAFLD with advanced fibrosis was estimated based on the fibrosis‐4 index (FIB‐4) and NAFLD fibrosis score (NFS).ResultsA total of 71,254 subjects were included in the final analysis. The overall prevalence of NAFLD was 25.8%. There was a significant, 2‐fold difference in NAFLD prevalence between males (37.4%) and females (18.1%). NAFLD prevalence increased linearly with body mass index, triglycerides, and low‐density lipoprotein cholesterol regardless of threshold values, even in the absence of obesity. Among patients with NAFLD, 14% had diabetes mellitus, 31% had hypertension, and 48% had dyslipidemia. The estimated prevalence of NAFLD with advanced fibrosis was 1.7% and 1.0% according to FIB‐4 and NFS, respectively.ConclusionsThe prevalence of NAFLD was approximately one‐quarter of the general population in Japan. There was a linear relationship between NAFLD prevalence and various metabolic parameters, even in nonobese subjects. The prevalence of NAFLD with advanced fibrosis was estimated to be 1% to 2%.This article is protected by copyright. All rights reserved.

Metabolic management after sustained virologic response in elderly patients with hepatitis C virus: A multicenter study

“…In the Japanese general population, the prevalence of NAFLD was reported to decrease after peaking in the 50s for men and in the 60s for women. 46 In addition, advanced liver fibrosis in non-alcoholic steatohepatitis is often accompanied by a reduction in hepatic fat contents, known as burnt-out non-alcoholic steatohepatitis. 47 Based on the aforementioned, we hypothesized that age and liver fibrosis were related to the prevalence of MASLD in this present study.…”

Concordance between metabolic dysfunction‐associated steatotic liver disease and nonalcoholic fatty liver disease

“…Nonalcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease worldwide and is estimated to affect 25% of the population. [1][2][3] NAFLD increases the prevalence of hepatocellular carcinoma or liver failure and is an economic health burden. [4][5][6][7][8][9][10][11] In August 2023, a consensus group consisting of multiple academic institutions proposed a reclassification of NAFLD, introducing a new nomenclature of steatotic liver disease (SLD) and its corresponding subgroups, because the term NAFLD may be stigmatizing and has concerns regarding potential discriminatory implications.…”

Prevalence and Associated Factors of Liver Enzyme Abnormalities Among Bangladeshi Women: A Cross-Sectional Study

“…The global prevalence of NAFLD was approximately 37% in 2019 [9]. However, the prevalence varies by country: India reported 38.6% [10], Japan 25.8% [11], China 29.8% [12], Korea 30.3% [13], and Sri Lanka 32.6% [14]. A study conducted in Bangladesh found an overall NAFLD prevalence of 33.86% across genders and urban-rural regions [6].…”